314130 — Genome&Company Income Statement
0.000.00%
- KR₩153bn
- KR₩157bn
- KR₩14bn
Annual income statement for Genome&Company, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.8 | 151 | 451 | 14,085 | 14,296 |
Cost of Revenue | |||||
Gross Profit | 45.8 | 151 | 374 | 5,598 | 4,064 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13,867 | 26,779 | 36,538 | 71,597 | 71,714 |
Operating Profit | -13,821 | -26,629 | -36,087 | -57,512 | -57,418 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -84,669 | -31,186 | -36,004 | -58,033 | -51,855 |
Provision for Income Taxes | |||||
Net Income After Taxes | -84,669 | -31,186 | -36,004 | -56,950 | -50,653 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -84,669 | -30,732 | -34,117 | -51,838 | -47,466 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -84,669 | -30,732 | -34,117 | -51,838 | -47,466 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -10,562 | -3,182 | -2,537 | -3,683 | -3,251 |
Dividends per Share |